BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 28580765)

  • 1. In vitro evaluation of a basic fibroblast growth factor-containing hydrogel toward vocal fold lamina propria scar treatment.
    Erndt-Marino JD; Jimenez-Vergara AC; Diaz-Rodriguez P; Kulwatno J; Diaz-Quiroz JF; Thibeault S; Hahn MS
    J Biomed Mater Res B Appl Biomater; 2018 Apr; 106(3):1258-1267. PubMed ID: 28580765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of anti-fibrotic effects of select cytokines for vocal fold scar treatment.
    Chen H; Erndt-Marino J; Diaz-Rodriguez P; Kulwatno J; Jimenez-Vergara AC; Thibeault SL; Hahn MS
    J Biomed Mater Res B Appl Biomater; 2019 May; 107(4):1056-1067. PubMed ID: 30184328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery system of basic fibroblast growth factor using gelatin hydrogel for restoration of acute vocal fold scar.
    Kobayashi T; Mizuta M; Hiwatashi N; Kishimoto Y; Nakamura T; Kanemaru SI; Hirano S
    Auris Nasus Larynx; 2017 Feb; 44(1):86-92. PubMed ID: 27126068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of a novel collagen-gelatin scaffold with basic fibroblast growth factor for the treatment of vocal fold scar.
    Hiwatashi N; Hirano S; Mizuta M; Kobayashi T; Kawai Y; Kanemaru SI; Nakamura T; Ito J; Kawai K; Suzuki S
    J Tissue Eng Regen Med; 2017 May; 11(5):1598-1609. PubMed ID: 26119035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vocal fold myofibroblast profile of scarring.
    Branco A; Bartley SM; King SN; Jetté ME; Thibeault SL
    Laryngoscope; 2016 Mar; 126(3):E110-7. PubMed ID: 26344050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MERS versus Standard Surgical Approaches for Porcine Vocal Fold Scarring with Adipose Stem Cell Constructs.
    Woo JH; King SN; Hoffman H; Dailey S; Wang S; Christensen MB; Thibeault SL
    Otolaryngol Head Neck Surg; 2016 Oct; 155(4):612-23. PubMed ID: 27165681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hydrogel mechanical properties and mesh size on vocal fold fibroblast extracellular matrix production and phenotype.
    Liao H; Munoz-Pinto D; Qu X; Hou Y; Grunlan MA; Hahn MS
    Acta Biomater; 2008 Sep; 4(5):1161-71. PubMed ID: 18515199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vocal fold fibroblasts immunoregulate activated macrophage phenotype.
    King SN; Chen F; Jetté ME; Thibeault SL
    Cytokine; 2013 Jan; 61(1):228-36. PubMed ID: 23123198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tissue-specific, injectable acellular gel for the treatment of chronic vocal fold scarring.
    Xu CC; Mau T
    Acta Biomater; 2019 Nov; 99():141-153. PubMed ID: 31425889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocompatibility and efficacy of collagen/gelatin sponge scaffold with sustained release of basic fibroblast growth factor on vocal fold fibroblasts in 3-dimensional culture.
    Hiwatashi N; Hirano S; Mizuta M; Tateya I; Kanemaru S; Nakamura T; Ito J; Kawai K; Suzuki S
    Ann Otol Rhinol Laryngol; 2015 Feb; 124(2):116-25. PubMed ID: 25115594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rat excised larynx model of vocal fold scar.
    Welham NV; Montequin DW; Tateya I; Tateya T; Choi SH; Bless DM
    J Speech Lang Hear Res; 2009 Aug; 52(4):1008-20. PubMed ID: 19641079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of growth factors on extracellular matrix production by vocal fold fibroblasts in 3-dimensional culture.
    Luo Y; Kobler JB; Zeitels SM; Langer R
    Tissue Eng; 2006 Dec; 12(12):3365-74. PubMed ID: 17518673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracordal Injection of Basic Fibroblast Growth Factor in 100 Cases of Vocal Fold Atrophy and Scar.
    Hirano S; Sugiyama Y; Kaneko M; Mukudai S; Fuse S; Hashimoto K
    Laryngoscope; 2021 Sep; 131(9):2059-2064. PubMed ID: 33107605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing vocal fold fibroblast response to hyaluronan in 3D contexts.
    Munoz-Pinto DJ; Jimenez-Vergara AC; Gelves LM; McMahon RE; Guiza-Arguello V; Hahn MS
    Biotechnol Bioeng; 2009 Nov; 104(4):821-31. PubMed ID: 19718686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of vocal fold scarring by local application of basic fibroblast growth factor in a rat vocal fold injury model.
    Suzuki R; Kawai Y; Tsuji T; Hiwatashi N; Kishimoto Y; Tateya I; Nakamura T; Hirano S
    Laryngoscope; 2017 Feb; 127(2):E67-E74. PubMed ID: 27411786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of glycosaminoglycan identity on vocal fold fibroblast behavior.
    Jimenez-Vergara AC; Munoz-Pinto DJ; Becerra-Bayona S; Wang B; Iacob A; Hahn MS
    Acta Biomater; 2011 Nov; 7(11):3964-72. PubMed ID: 21740987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HGF and bFGF Secreted by Adipose-Derived Mesenchymal Stem Cells Revert the Fibroblast Phenotype Caused by Vocal Fold Injury in a Rat Model.
    Li X; Wang H; Xu W
    J Voice; 2022 Sep; 36(5):622-629. PubMed ID: 32921552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor β3 for the prevention of vocal fold scarring.
    Ohno S; Hirano S; Kanemaru S; Kitani Y; Kojima T; Ishikawa S; Mizuta M; Tateya I; Nakamura T; Ito J
    Laryngoscope; 2012 Mar; 122(3):583-9. PubMed ID: 22252900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of basic fibroblast growth factor on rat vocal fold fibroblasts.
    Suehiro A; Hirano S; Kishimoto Y; Tateya I; Rousseau B; Ito J
    Ann Otol Rhinol Laryngol; 2010 Oct; 119(10):690-6. PubMed ID: 21049855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porcine Vocal Fold Lamina Propria-Derived Biomaterials Modulate TGF-β1-Mediated Fibroblast Activation in Vitro.
    Mora-Navarro C; Badileanu A; Gracioso Martins AM; Ozpinar EW; Gaffney L; Huntress I; Harrell E; Enders JR; Peng X; Branski RC; Freytes DO
    ACS Biomater Sci Eng; 2020 Mar; 6(3):1690-1703. PubMed ID: 33455360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.